Immunology drug developer Odyssey prices upsized IPO
ORIGINAL SOURCE →via Seeking Alpha
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] Intentional and Intersectional: Servicing A Modern Payments Journey
- [FINANCE] Deals: Fitbit Air pre-order offers, Pixel 10 Pro/XL up to $500 off, Legion Go 2 Windows handheld $482 off, more
- [FINANCE] TeraWulf’s $21 million HPC revenue surpasses bitcoin mining for first time in Q1
- [FINANCE] Telos Q1 2026 Earnings Preview
- [FINANCE] ECB’s Lagarde Pushes Back on Euro Stablecoins, Warns of ‘Structural Weaknesses’
- [FINANCE] Hain Celestial Q3 2026 Earnings Preview